Last updated: 05/11/2023
COVID-19 benefits
The COVID-19 federal public health emergency (PHE) ended on May 11, 2023. Please review the following information to understand your COVID-19 benefits with Humana.
Humana Commercial Group (those who receive insurance through their employer), Medicare Advantage and Medicaid members:
Yes. However, starting May 12, 2023, the amount you will be required to pay for covered COVID-19 benefits – including testing, testing-related services and treatment – may change. Visit MyHumana.com or call the number on the back of your Humana member ID card for more details on changes to COVID coverage requirements beginning May 12, 2023.
Humana Commercial Group members:
Out-of-pocket costs for covered COVID-19 testing may vary by plan, but in general will be similar to other common diagnostic tests, such as influenza. Please refer to MyHumana.com or call the number on the back of your card to learn more.
Please note: Puerto Rico members will continue to have $0 cost share.
Humana Commercial Group members will continue to be eligible for COVID-19 testing when a
Humana Commercial Group members may NOT be eligible for coverage of COVID-19 testing for any indications other than those listed above including, but not limited to, the following:
Humana Medicare Advantage members:
After the COVID-19 PHE ends, applicable member cost share would apply for covered COVID-19 testing.
You can verify your member plan benefits by logging in to MyHumana.com or calling the number on the back of your card to learn more.
Humana Medicaid members:
Medicaid plans will continue to follow state requirements for COVID-19 testing.
Humana Commercial Group members:
Complete all information requested on the Health Benefits Claim Form, which can be found here:
Please note: It can take up to 30 days to process the claim, and the reimbursement will be sent as a check to the home address on file.
Humana Commercial Group and Humana Medicare Advantage members:
No. Access to free at-home, OTC COVID-19 tests will end when the COVID-19 PHE ends on May 11.
Humana Medicaid members
State Medicaid programs must provide coverage without cost sharing for COVID-19 testing until the last day of the first calendar quarter that begins one year after the last day of the COVID-19 PHE. That means with the COVID-19 PHE ending on May 11, 2023, this mandatory coverage will end on September 30, 2024, after which coverage may vary by state.
Humana Commercial Group members:
On January 15, 2022, the U.S. Department of Health and Human Services announced that all private health insurance members are eligible to receive up to 8 at-home, OTC COVID-19 tests per 30 days (or calendar month) at no out-of-pocket cost. This program will end on May 11. However eligible test kits purchases may be reimbursed if bought prior to May 12. Submitted eligible test kits must meet the following criteria:
Please note: Humana does not manufacture or make available these at-home, OTC COVID-19 tests for members. You may find them at local pharmacies, local stores or trusted online retailers.
To submit an OTC COVID-19 test kit purchase made prior to May 12, 2023, for reimbursement:
Important note: If you purchase your test kit(s) using your HSA and then file for reimbursement, you are required by law to pay back your HSA account with the funds you receive from Humana. As such, for simplicity you may prefer to purchase using a different method of payment.
Humana Commercial Group members:
Yes. COVID-19 vaccines will continue to be covered at $0 cost share when you visit an in-network provider. Vaccines administered by an out-of-network provider will be subject to plan cost-sharing.
Humana Medicare Advantage members
There will continue to be a $0 cost share for COVID-19 vaccines across Humana’s Medicare Advantage plans.
Humana Medicaid members:
Medicaid plans will follow state requirements for coverage of COVID-19 vaccines.